Filtro de Convocatorias
select
Convocatorias

Topic identifier: IMI2-2018-15-01 Topic: Integrated research platforms enabling patient-centric drug development Type of action: IMI2-RIA Research and Innovation action Deadline Model: Two-stage 1st Deadline: 24 October 2018 at 17:00:00 2nd stage Deadline: 15 May 2019 at 17:00:00 Scope: The action aims to address these issues by creating, in a collaborative rather than competitive manner, a reusable and modular approach for the design and execution of patient-centric platform trials. Further info: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/imi2-2018-15-01.html

COMISION EUROPEA
Fecha publicación: 18/07/2018 Fecha límite: 15/05/2019
Más Información
Resumen y Bases

Topic identifier: IMI2-2018-15-02 Topic: Blockchain Enabled Healthcare Type of action: IMI2-RIA Research and Innovation action Deadline Model: Two-stage 1st Deadline: 24 October 2018 at 17:00:00 2nd stage Deadline: 15 May 2019 at 17:00:00 Scope: The overall objective of the agile project generated by this topic is to establish a common blockchain ecosystem for pharmaceutical development, manufacturing, and distribution that provides an incentive and serves as the basis for all participants to engage, adopt, and benefit from. Further info: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/imi2-2018-15-02.html

COMISION EUROPEA
Fecha publicación: 18/07/2018 Fecha límite: 15/05/2019
Más Información
Resumen y Bases

Topic identifier: IMI2-2018-15-03 Topic: Microenvironment imposed signatures in tissue and liquid biopsies in immune- mediated diseases Type of action: IMI2-RIA Research and Innovation action Deadline Model: Two-stage 1st Deadline: 24 October 2018 at 17:00:00 2nd stage Deadline: 15 May 2019 at 17:00:00 Scope: The ultimate goal to be achieved by the consortium is to identify key organ and disease-specific signatures with correlates in body fluids that may predict disease, track progression and/or therapeutic response. These signatures will enable tailored treatment pathways to the disease mechanism and ultimately provide superior therapeutic benefit to patients. Further info: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/imi2-2018-15-03.html

COMISION EUROPEA
Fecha publicación: 18/07/2018 Fecha límite: 15/05/2019
Más Información
Resumen y Bases

Topic identifier: IMI2-2018-15-04 Topic: Emerging translational safety technologies and tools for interrogating human immuno-biology Type of action: IMI2-RIA Research and Innovation action Deadline Model: Two-stage 1st Deadline: 24 October 2018 at 17:00:00 2nd stage Deadline: 15 May 2019 at 17:00:00 Scope: This topic aims to establish a public-private consortium that will enhance translational safety assessment approaches for immunomodulatory therapeutics (spanning oncology and non-oncology indications), with an emphasis on evaluating human-relevance. Further info: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/imi2-2018-15-04.html

COMISION EUROPEA
Fecha publicación: 18/07/2018 Fecha límite: 15/05/2019
Más Información
Resumen y Bases

Topic identifier: IMI2-2018-15-05 Topic: Development and validation of translational platforms in support of synaptopathy drug discovery Type of action: IMI2-RIA Research and Innovation action Deadline Model: Two-stage 1st Deadline: 24 October 2018 at 17:00:00 2nd stage Deadline: 15 May 2019 at 17:00:00 Scope: The overarching aim of this topic is to develop an improved understanding of the causative or contributory role of synaptic alterations in CNS disorders, which must be valid and applicable to drug discovery and development across the diverse therapeutic CNS areas. The aim is to construct a precompetitive research consortium focused on furthering our scientific understanding of how synaptopathies can elicit or contribute to brain disorders. Further info: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/imi2-2018-15-05.html

COMISION EUROPEA
Fecha publicación: 18/07/2018 Fecha límite: 15/05/2019
Más Información
Resumen y Bases

Topic identifier: IMI2-2018-15-06 Topic: Digital endpoints in neurodegenerative and immune-mediated diseases Type of action: IMI2-RIA Research and Innovation action Deadline Model: Two-stage 1st Deadline: 24 October 2018 at 17:00:00 2nd stage Deadline: 15 May 2019 at 17:00:00 Scope: Subtle impairments in accomplishing daily activities are sometimes reported among the first signs of a disorder that will progressively develop towards more severe disabilities for individuals affected with NDD and IMID. Further info: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/imi2-2018-15-06.html

COMISION EUROPEA
Fecha publicación: 18/07/2018 Fecha límite: 15/05/2019
Más Información
Resumen y Bases

Topic identifier: IMI2-2018-15-07 Topic: AMR Accelerator programme Pillar A: Capability Building Network to accelerate and validate scientific discoveries Type of action: IMI2-RIA Research and Innovation action Deadline Model: Two-stage 1st Deadline: 24 October 2018 at 17:00:00 2nd stage Deadline: 15 May 2019 at 17:00:00 Scope: The Capability Building Network (CBN), Pillar A of the IMI2 AMR Accelerator programme, will work to address the innovation gap in the AMR space by enabling pre-competitive research in the treatment and prevention of multi-drug resistant infections. Further info: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/imi2-2018-15-07.html

COMISION EUROPEA
Fecha publicación: 18/07/2018 Fecha límite: 15/05/2019
Más Información
Resumen y Bases

Topic identifier: IMI2-2018-15-08 Topic: AMR Accelerator programme Pillar B: Tuberculosis drug development network to accelerate and validate scientific discoveries and advance the R&D pipeline of new and innovative agents to address the global tuberculosis epidemic Deadline Model: Two-stage 1st Deadline: 24 October 2018 at 17:00:00 2nd stage Deadline: 15 May 2019 at 17:00:00 Scope: The TB drug development Network (TBDDN), pillar B of the IMI2 AMR Accelerator programme, will function as a platform based on the principles of open innovation to advance discovery, preclinical and early clinical projects in the field of TB and MDR-TB. Further info: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/imi2-2018-15-08.html

COMISION EUROPEA
Fecha publicación: 18/07/2018 Fecha límite: 15/05/2019
Más Información
Resumen y Bases

HORIZON 2020 WP 2018 - 2020 DIGITAL TRANSFORMATION IN HEALTH AND CARE. Call: SC1-DTH-01-2019 Type of action: RIA TOPIC : Big data and Artificial Intelligence for monitoring health status and quality of life after the cancer treatment. Opening: 16/10/2018 Deadline: 24/04/2019 (at 17:00 Brussels local time) Budget of the Project: 3 - 5 M€ Total budget for this Call: 35 M€ FURTHER INFO: http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-dth-01-2019.html

COMISION EUROPEA
Fecha publicación: 27/10/2017 Fecha límite: 24/04/2019
Más Información
Resumen y Bases

HORIZON 2020 WP 2018 - 2020 DIGITAL TRANSFORMATION IN HEALTH AND CARE. Call: SC1-DTH-05-2019 Type of action: PPI (Public Procurement of Innovation solutions TOPIC: Large scale implementation of digital innovation for health and care in an ageing society. Opening: 16/10/2018 Deadline: 24/04/2019 (at 17:00 Brussels local time) Budget of the Project: 2 - 5 M€ Total budget for this Call: 10 M€ FURTHER INFO: http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-dth-05-2019.html

COMISION EUROPEA
Fecha publicación: 27/10/2017 Fecha límite: 24/04/2019
Más Información
Resumen y Bases

HORIZON 2020 WP 2018 - 2020 DIGITAL TRANSFORMATION IN HEALTH AND CARE. Call: SC1-HCC-02-2019 Type of action: CSA TOPIC: Support for the large scale uptake of open service platforms in the Active and Healthy Ageing domain. Opening: 16/10/2018 Deadline: 24/04/2019 (at 17:00 Brussels local time) Budget of the Project: 1,5 M€ Total budget for this Call: 1,5 M€ FURTHER INFO: http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-hcc-02-2019.html

COMISION EUROPEA
Fecha publicación: 27/10/2017 Fecha límite: 24/04/2019
Más Información
Resumen y Bases

HORIZON 2020 WP 2018 - 2020 TRUSTED DIGITAL SOLUTIONS AND CYBERSERCURITY IN HEALTH AND CARE. Call: SC1-DTH-09-2019 Type of action: IA (Innovation Action) TOPIC: Scaling up the univocal Identification of Medicinal Products Opening: 16/10/2018 Deadline: 24/04/2019 (at 17:00 Brussels local time) Budget of the Project: 5 - 8 M€ Total budget for this Call: 19 M€ FURTHER INFO: http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-dth-09-2019.html

COMISION EUROPEA
Fecha publicación: 27/10/2017 Fecha límite: 24/04/2019
Más Información
Resumen y Bases

HORIZON 2020 WP 2018 - 2020 TRUSTED DIGITAL SOLUTIONS AND CYBERSERCURITY IN HEALTH AND CARE. Call: SC1-DTH-11-2019 Type of action: IA (Innovation Actions) TOPIC: Large Scale pilots of personalised & outcome based integrated care. Opening: 16/10/2018 Deadline: 24/04/2019 (at 17:00 Brussels local time) Budget of the Project: 4 - 6 M€ Total budget for this Call: 20 M€ FURTHER INFO: http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-dth-11-2019.html

COMISION EUROPEA
Fecha publicación: 27/10/2017 Fecha límite: 24/04/2019
Más Información
Resumen y Bases

SOCIEDAD ESPAÑOLA DE ONCOLOGÍA MÉDICA PREMIOS HITOS ONCOLÓGICOS 2016 Se otorgarán tres premios a los mejores casos clínicos en oncología de 2015 y 2016. Dotación económica: 1º premio: 1.200 €; 2º y 3º premio: 500 €

SOCIEDAD ESPAÑOLA DE ONCOLOGÍA MÉDICA
Fecha publicación: 03/10/2016 Fecha límite:
Más Información
Resumen y Bases